| Ticker | Name | Research | View | What's said | Source |
|---|---|---|---|---|---|
| AAPL | Apple | QT · SA · STK · FA | Neutral | Ternus handoff. Q3 revenue +16% Y/Y to $109.4B ($0.5B beat), EPS $2.02 ($0.13 beat) — June-quarter records, yet shares fell ~6%. Tariff refunds added $0.11 but the underlying beat held. iPhone +22% to a record $54.3B, Mac +29% to a record $10.4B, China rebounded 22% to $18.8B; Services slowed to +12% ($30.7B). Tim Cook's final call before John Ternus takes over in September, and he leaves a good problem: Apple cannot make enough devices — unexpectedly strong iPhone and Mac demand exhausted its flexibility to secure advanced chips, hitting Mac this quarter and broadening to iPhone, Mac and iPad in September. Guide of 9%–11% revenue growth (iPhone mid-teens) still came in below consensus. Memory is the bigger margin problem: Cook calls it a "hundred-year flood," with rising prices already forcing Mac and iPad price increases; ex-tariff gross margin fell sequentially and another step down is expected in Q4 as cheap inventory runs out. R&D +32% to $11.7B on the AI push; Cook hinted heavy Siri users could be steered to pricier iCloud+ tiers. (Recap, not a stance call.) | article ↗ |
| META | Meta Platforms | QT · SA · STK · FA | Neutral | The AI bill comes due. Q2 revenue +28% Y/Y to $60.8B ($0.5B beat); GAAP EPS −13% to $6.18 on $2.4B of youth-safety legal charges and $1.2B of severance (ex-items operating income would have risen 9%, not fallen 8%). Shares fell as much as 10% on two things. Free cash flow nearly disappeared: $31.9B operating cash flow against $31.1B of capex and finance leases left $784M, −91% Y/Y; Meta issued $24.9B of debt and repurchased no stock — the first quarter AI spending consumed the whole FCF, halted buybacks and pushed it into the debt market. The capex floor moved up again: FY26 narrowed to $130–145B from $125–145B, the bottom end raised a second straight quarter, with the new 1 GW El Paso venture structured so BlackRock owns 80% while Meta keeps 20% and leases the entire campus. The irony: AI is already paying inside ads — revenue +27% (impressions +14%, price/ad +12%), new models +8% ad clicks and +16% Facebook conversions, Advantage+ past a $75B run rate. Family DAP 3.60B, Instagram past 2B daily, Threads past 500M monthly; FoA 'other' revenue above $1B for the first time. Zuck floated selling paid model access and leasing excess compute at a "meaningful premium" to cost. Reality Labs lost another $4.6B. Q3 guide $61–64B (midpoint below consensus), FY26 expenses raised to $165–169B. (Recap, not a stance call.) | article ↗ |
| Samsung | Samsung Electronics | — | Neutral | Records meet a rout. Q2 revenue +130% Y/Y to a record KRW 171.5T (~$119B) and operating profit up more than 18-fold to a record KRW 89.5T (~$62B), both roughly in line with the preannouncement; net profit KRW 71.6T, +~1,300%. The chip division did essentially all of it — and the stock still finished lower, down more than 40% from its June peak in a chip-sector rout on AI-spending fears, with the Kospi logging its worst month on record. Management pushed the shortage horizon out again: memory chief Jaejune Kim said constraints worsen in 2027 and now persist through 2028, with this year's unmet demand deferred to next; 60–70% of HBM capacity is locked under multi-year contracts (five major AI data-center customers signed, five more in negotiation); it shipped the industry's first HBM4E samples, staying ahead of SK Hynix. Mobile swung to a ~KRW 700B loss, squeezed by the same component prices fuelling the memory boom. DRAM/NAND prices guided up 15–20% sequentially into Q3. "A low P/E means little when the market is betting the peak is near." (Recap, not a stance call.) | article ↗ |
| V | Visa | QT · SA · STK · FA | Neutral | Volume accelerates. Q3 net revenue (June quarter) +14% Y/Y to $11.6B ($200M beat), adjusted EPS +11% to $3.32 ($0.09 beat), and total payment volume cleared $4 trillion in a quarter for the first time. Every volume metric sped up from Q2: payments volume 9%→10%, cross-border 12%→13%, processed transactions 9%→10%. CEO Ryan McInerney is leaning into an AI-and-stablecoin pivot — a new Visa Stablecoin Platform and an OpenAI agentic-commerce partnership — while cutting ~2,600 jobs (~7% of headcount, mostly tech and product) the same day. The cost of the volume shows in client incentives, the contra-revenue Visa pays partners: +18% to $4.7B, outpacing revenue. Visa trimmed full-year net revenue growth to the low end of low teens and moved several metrics to the bottom of their ranges; Q4 guided to high-end-of-low-double-digit revenue growth and low-end-of-mid-teens EPS, with management pinning the softer guide on currency volatility it expects to persist. (Recap, not a stance call.) | article ↗ |
| MA | Mastercard | QT · SA · STK · FA | Neutral | The crack didn't widen. Q2 revenue +14% Y/Y to $9.3B ($220M beat) and adjusted EPS +21% to $5.04 ($0.26 beat). The feared Middle East hit moderated — CFO Sachin Mehra said it was less severe than expected — and cross-border volume held at 12%, down only slightly from Q1's 13%. The engine is tilting toward services: value-added services +20% (18% currency-neutral), accelerating sequentially, with cybersecurity increasingly central after the Recorded Future deal; payment network revenue +10% on 8% gross-dollar-volume growth to $2.9T; operating margin expanded to 61.1% from 59.9%. FY26 net revenue guidance raised to the "low teens" and $4.9B of stock repurchased. April's cross-border slowdown proved transitory, and Mastercard's higher exposure turned into a tailwind. (Recap, not a stance call.) | article ↗ |
| ABBV | AbbVie | QT · SA · STK · FA | Neutral | Growth engines hold. Q2 revenue +10% Y/Y to $17.0B ($230M beat), adjusted EPS $3.65 ($0.04 beat), adjusted operating margin +400 bps to 48.3%. Immunology +15% to $8.8B: Skyrizi +24% to $5.5B and Rinvoq +25% to $2.5B, both ahead of expectations, with management saying Skyrizi's momentum has not slowed since J&J launched its oral psoriasis competitor Icotyde. Humira fell another 36% to $756M and is increasingly irrelevant to the growth story. Neuroscience +20% to $3.2B — Vraylar crossed $1B and Parkinson's treatment Vyalev reached $256M; Botox improved a third consecutive quarter while Juvederm stayed soft and the faster-acting toxin awaits US approval. AbbVie raised its underlying revenue outlook by another $300M but lowered adjusted EPS guidance to $13.87–$14.07, reflecting $0.14 of dilution from the planned $10.9B Apogee Therapeutics acquisition, partly offset by stronger operations. The question: whether Apogee extends immunology dominance into the 2030s without slowing deleveraging or distracting from the Botox recovery. (Recap, not a stance call.) | article ↗ |
| LRCX | Lam Research | QT · SA · STK · FA | Neutral | The ramp steepens. Q4 revenue (June quarter) +30% Y/Y to $6.7B ($50M beat), adjusted EPS $1.82 ($0.14 beat), gross margin 52% — the highest in 20 years — and a record 38% operating margin. Unlike the semi-equipment names that sold off this season, Lam rallied, because the Q1 FY27 guide was far ahead: September-quarter revenue of $8.1B at the midpoint against ~$7.1B consensus (more than 20% sequential growth) with EPS $2.00–$2.30 vs ~$1.84. AI demand is broadening across the franchises: NAND revenue doubled sequentially on 200+ layer architectures and AI's appetite for persistent memory; advanced-packaging growth guidance jumped to more than 70% Y/Y on chiplets, HBM stacks and panel-level packaging; CSBG +17% sequentially to $2.5B. The margin framework moved up too — mid-50s gross and mid-40s operating margin targeted over the next several years, tracking to a high-30s share of WFE faster than the 2025 Investor Day plan. CEO Tim Archer called for a third straight year of outperforming WFE. The constraint is now whether customers can absorb tools at this delivery pace. (Recap, not a stance call.) | article ↗ |
| KO | Coca-Cola | QT · SA · STK · FA | Neutral | Volume carries the quarter. Q2 revenue +7% Y/Y to $13.4B ($230M beat) and comparable EPS +11% to $0.97 ($0.04 beat), with organic revenue +6% against a ~3.6% consensus; the stock jumped ~5% to a fresh high, up more than 20% this year, after absorbing a shipment-timing drag. Volume did the work: global unit case volume +5%, positive in every segment, led by India, China, the US and Brazil, while price/mix added just 2% on CEO Henrique Braun's affordability-over-pricing pivot. Zero Sugar +16% and Diet Coke +7%; the FIFA World Cup sponsorship lifted Trademark Coca-Cola volume 5% and Powerade 8%. Comparable operating margin expanded to 35.6% from 34.7% despite the affordability drag. FY26 comparable EPS growth raised to 9%–10% (from 8%–9%) with organic revenue growth now ~5% (vs ~4.6% consensus). Headwinds in the back half: six fewer shipping days in Q4 and the CCBA (Coca-Cola Beverages Africa) divestiture, framed as a 2%–3% revenue headwind closing late Q3 or Q4. With price/mix deliberately at 2%, volume is the lever. (Recap, not a stance call.) | article ↗ |
| PG | Procter & Gamble | QT · SA · STK · FA | Neutral | Iran cost bites. Q4 revenue (June quarter) +2% Y/Y to $21.2B ($180M miss) and core EPS $1.43 ($0.02 beat) but down from $1.48 a year ago. Organic sales were flat against a ~1.9% consensus, with volume, pricing and mix all neutral — a clear deceleration after last quarter's 3% rebound, and every segment except beauty fell short. Beauty stayed the bright spot at 4% organic (6% reported) while grooming and baby/feminine/family care each fell 1%; underneath the weak print, P&G grew Greater China market share for the first time in 15 quarters. The FY27 guide set the tone: core EPS $6.89–$7.11 (midpoint $7.00 vs ~$7.02 consensus) on organic sales growth of just 1%–3%, absorbing a ~$1B after-tax headwind from higher raw materials, energy and transportation tied to the Iran war — part of a $0.56-per-share drag worth 8% of core EPS growth, with guidance assuming Brent near $90 (escalation makes it worse). The bull case is that it's macro, not share loss; the tell is first-half FY27 organic growth, since management promises sequential acceleration while absorbing the cost peak up front. (Recap, not a stance call.) | article ↗ |
| ARM | Arm Holdings | QT · SA · STK · FA | Neutral | Data center offsets phones. Q1 FY27 revenue (June quarter) +22% Y/Y to $1.29B ($20M beat) and non-GAAP EPS +29% to $0.45 ($0.05 beat), with licensing +23% to $574M and royalties +22% to $715M both clearing consensus (royalties beating after last quarter's memory-driven miss) — yet shares fell ~7-8%, the clean beat overshadowed by the smartphone slowdown and a broad semiconductor selloff on AI-spending doubts. Data center is doing what the bull case needs: data-center royalties more than doubled Y/Y for a second straight quarter, Neoverse shipments passed 1.5 billion cores, and Nvidia, AWS, Google and Microsoft are all deepening adoption; the AGI CPU pipeline now exceeds $2B through FY28, double last quarter's $1B — though guidance still reflects only that initial $1B on wafer supply. CFO Jason Child said royalty growth slows to low-to-mid teens in Q2 on smartphone weakness, mitigated by pushing customers to higher-rate Armv9 and Compute Subsystems. Q2 FY27 guide ~$1.38B (vs ~$1.34B) and EPS ~$0.47 (vs ~$0.45). Capacity is the real question — watch whether Arm raises the $1B. (Recap, not a stance call.) | article ↗ |
| KLAC | KLA Corporation | QT · SA · STK · FA | Neutral | 2027 gets bigger. Q4 revenue (June quarter) +15% Y/Y to a record $3.7B ($60M beat) and adjusted EPS $1.05 (beat by $0.05) — per-share figures reflect the June 11 10-for-1 split, so they aren't comparable to prior quarters at face value. A clean beat-and-raise, but the stock sold off after a pre-earnings run. KLA lifted its 2026 wafer-equipment market view (including advanced packaging) to the low $150B range from "$140 billion plus" last quarter; CEO Rick Wallace said AI demand signals have strengthened materially since March and carried his 2027 conviction further across logic, DRAM, HBM, NAND and packaging. Advanced-packaging process-control revenue was raised again to ~$1.1B in 2026, up more than 70% Y/Y. The catch: memory pricing is a ~100-basis-point drag on gross margin that CFO Bren Higgins said likely continues through 2027, because KLA can't reprice orders already taken. Q1 FY27 guide ~$4.0B (vs ~$3.9B) and EPS ~$1.16 (vs ~$1.13), with second-half growth around 20% over the first half. Watch whether gross margin holds 62.5% as volume ramps. (Recap, not a stance call.) | article ↗ |
| AZN | AstraZeneca | QT · SA · STK · FA | Neutral | Pipeline on trial. Q2 revenue +6% Y/Y to $15.4B ($50M miss) while core EPS was $2.63 ($1.36 beat). The stock is still down year-to-date after the Wainua heart drug missed its primary endpoint in CARDIO-Transform — a rare late-stage failure for a company that puts its trial success rate at 75% — so the question was whether one high-profile miss says anything about the pipeline behind it. Oncology carried the quarter, +6% cc to $7.3B: Imfinzi (lung) +27% to $1.8B, Enhertu (breast) +31% to $888M, Tagrisso still top seller +6% to $1.9B, offsetting patent-cliff declines in Farxiga and Brilinta. The pipeline delivered hits and misses — sonesitatug vedotin, the first pivotal readout from the wholly-owned ADC portfolio, improved gastric-cancer survival but missed progression-free survival, and Ultomiris disappointed in a rare blood disorder; against those, CEO Pascal Soriot pointed to positive data from six Phase III programs and insisted the $80B 2030 revenue target is risk-adjusted, assumes failures like Wainua, and needs no M&A. FY2026 guidance reiterated (mid-to-high single-digit revenue growth, low-double-digit core EPS growth). Twenty-plus readouts land over 18 months; Datroway (lung) and camizestrant (breast) matter most. (Recap, not a stance call.) | article ↗ |
| EADSY | Airbus | SA · STK | Neutral | The ramp finally shows. H1 revenue +12% Y/Y to €33.2B ($37.8B), with Q2 +28% to €20.5B (€0.25B beat) and Q2 adjusted EBIT +54% to €2.43B (€0.24B beat). Airbus delivered 351 commercial aircraft in H1, up from 306, with the acceleration concentrated in Q2 after a dismal 114-plane Q1 — some analysts had feared a target cut like 2022, 2024 and 2025, but the Q2 cadence made the ~870 full-year goal look attainable. Commercial aircraft adjusted EBIT rose to €2.0B on volume, though weaker dollar hedges capped it; Defense and Space kept overdelivering, nearly doubling adjusted EBIT to €487M on order intake up to €9.3B. Two watch items: free cash flow was negative €1.2B on a planned inventory build, and the Pratt & Whitney engine shortage still gates the new rate targets (70–75 A320s a month by end-2027). FY26 guidance reaffirmed (~870 deliveries, ~€7.5B adjusted EBIT, ~€4.5B FCF) with a new 2029 bar of €12–13B adjusted EBIT set last week. Roughly 519 aircraft must ship in H2 to hit 870 — watch whether the monthly rate holds or the back-half concentration strains suppliers again. (Recap, not a stance call.) | article ↗ |
| QCOM | Qualcomm | QT · SA · STK · FA | Neutral | Diversification on trial. Q3 FY26 revenue (June quarter) −4% Y/Y to $9.9B ($280M beat) and adjusted EPS $2.21 ($0.01 miss); shares sold off on an accelerating Apple step-down and a Q4 EPS guide well under consensus. CFO Akash Palkhiwala reiterated that China OEM handset revenue bottomed in Q3 and returns to double-digit sequential growth in Q4, but handset revenue still fell 20% to $5.1B on the memory crunch — and Qualcomm now expects its modem share on the new iPhone to be "materially lower" than the prior 20% estimate, with the step-down accelerating from Q4 on supply constraints. The other side: automotive surged 61% to $1.6B (FY26 exit run-rate ~$7B) and the two data-center custom-silicon wins start generating revenue in December, feeding a raised FY29 non-handset target of $40B. Q4 guide $9.7–10.5B (midpoint above the ~$10.0B consensus) but EPS $2.05–2.25 under the ~$2.35 consensus — the gap is QCT margins compressed by memory costs, with double-digit price increases across end markets starting September 1 to claw it back. The diversification is real and ahead of plan, but racing a modem business disappearing faster than expected. (Recap, not a stance call.) | article ↗ |
| BA | Boeing | QT · SA · STK · FA | Neutral | Cash turns positive. Q2 revenue +8% Y/Y to $24.6B ($330M beat) while the core loss of $0.76/share missed by $0.45 on a fresh Air Force One charge — but free cash flow turned positive at $631M against −$200M a year ago, and backlog hit a record $715B across more than 6,200 commercial jets. Boeing delivered 171 aircraft, +14% and the highest quarterly total since 2018, narrowing the commercial division's operating loss; 737 output is moving from 42 to 47 a month with the new Everett North Line activated in July and a year-end target of 52. The 737 MAX 7 and MAX 10 completed certification flight testing and the 777X cleared FAA approval to begin its own, all tracking to 2027 first deliveries. Two drags: the $280M charge on the fixed-price VC-25B (Air Force One) program — roughly four years late with over $1B of overruns Boeing eats, first delivery still 2028 — and a cash beat that leaned on ~$1.5B of customer advances, with a $700M DOJ payment hitting Q3 that management expects to hold FCF to the low hundreds of millions. No revenue/EPS guidance as usual, but FY26 FCF of $1–3B reaffirmed (its first positive annual figure since 2023); debt cut $1.3B, 173 orders booked at Farnborough. The FAA proposed inspections of hundreds of 737 MAX jets over improperly installed seats, and the China order tied to a Trump-Xi summit didn't materialise. Watch the 47/month rate. (Recap, not a stance call.) | article ↗ |
| SBUX | Starbucks | QT · SA · STK · FA | Neutral | Measurable momentum. Q3 revenue (June quarter) −1% Y/Y to $9.3B ($200M beat) and adjusted EPS +70% to $0.85 ($0.20 beat) — the revenue decline is entirely the China deconsolidation. The critical indicator: global comparable sales +8% against a ~6% consensus, with US comps also +8% on 4% transaction growth — the fourth straight positive comp after seven negative quarters, accelerating from 6% last quarter. Store "uplifts" passed 1,000 across North America (the full-year goal, hit early; now targeting at least 1,500 by year-end), US 90-day active Rewards members reached 35.8 million, and food attach hit a Q3 record. Non-GAAP operating margin expanded 430 bps to 14.4% — with a caveat: North America margin rose only to 13.6% from 13.3%, and the consolidated expansion leaned on tariff refunds covering three quarters of duties plus a favourable tax comparison, so management said the year-to-date view is the more normalised read. China is now a 40% licensed JV with Boyu Capital, contributing just $53M of revenue at a margin above 100% (flattering international metrics). FY26 guidance raised again — global comps nearing 6%, consolidated margin above 11%, Q4 US comps 6.5%+; leverage down to 2.9x after repaying ~$1.8B with China proceeds. Watch whether North America margin keeps expanding on its own. (Recap, not a stance call.) | article ↗ |
| FTNT | Fortinet | QT · SA · STK · FA | Neutral | The surge extends. Q2 revenue +26% Y/Y to $2.05B ($160M beat) and non-GAAP EPS +41% to $0.90 ($0.15 beat); billings +33% to $2.37B, product revenue +52% to $773M, non-GAAP operating margin a Q2-record 38%, free cash flow more than tripled to $966M. Every headline number accelerated from an already-strong Q1, without pull-forward or channel stuffing. The platform bet is paying: the renamed "SASE Firewall" (secure networking + Unified SASE) grew 34% to over $2B, winning against every top SASE competitor, and FortiSASE adoption reached 90% of large enterprise customers, up from 18% a quarter ago. But the mix was lopsided — product +52% versus service revenue +14% to $1.27B, so the beat was front-loaded hardware rather than the recurring stream, and management baked a high-single-digit pricing benefit into second-half billings. FY26 guidance raised across every line: revenue $8.02–8.18B (vs ~$7.81B consensus), billings $9.35–9.55B, non-GAAP EPS $3.41–3.47 (vs ~$3.16), a second straight broad raise. Service revenue is the tell on sustainability. (Recap, not a stance call.) | article ↗ |
| UPS | United Parcel Service | QT · SA · STK · FA | Neutral | The reset lands. Q2 revenue +8% Y/Y to $22.8B ($960M beat) and adjusted EPS +14% to $1.76 ($0.10 beat) — after years of declines, UPS finally posted top-line and adjusted operating-profit growth in the same quarter. GAAP profit still fell from $1.51 to $0.71 on an $891M workforce-cut charge, compressing GAAP operating margin to 4.1% (−450 bps). CEO Carol Tomé's 18-month Amazon glide-down is essentially complete, with Amazon now 9% of revenue, down from a pandemic peak above 13%; UPS removed about 2 million daily pieces of lower-quality volume and $4.5B of expenses, pivoting to premium: healthcare cleared $3B of revenue for a second straight quarter (lifted by refrigerated GLP-1 shipments), automation now handles 68.5% of US volume at roughly 28% lower cost per piece than non-automated buildings, US Domestic operating profit rose more than 20%, and the China-to-US lane returned to growth in May. FY26 guidance raised across the board — revenue ~$91.2B (vs ~$90.4B) and adjusted EPS ~$7.22 (vs ~$7.13) — reversing Q1's flat guide, with ~8.8% US Domestic operating margin targeted in the second half. The back half is where the operating leverage should show. (Recap, not a stance call.) | article ↗ |
| CDNS | Cadence Design Systems | QT · SA · STK · FA | Neutral | AI demand compounds. Q2 revenue +24% Y/Y to $1.6B (in line) and non-GAAP EPS $2.11 ($0.05 beat), with backlog to a record $8.1B (from $8.0B in Q1) and $4.2B set to convert within twelve months. CEO Anirudh Devgan's framing: autonomous agents call Cadence's underlying engines more often, so agentic adoption lands as higher consumption of tools customers already license. IP revenue grew 43%, which Devgan said was mostly organic rather than the acquired Hexagon design business; CFO John Wall described hardware as supply-constrained heading into another record year, and guided second-half adjusted margins to 43.75%–44.75% (below Q2's 45.5%) on deliberate integration and growth investment. FY26 revenue raised to $6.26–6.34B (vs ~$6.21B consensus), lifting the full year by $125M and implying 19% growth in what Devgan called the largest single-quarter raise the company has made. But management still hasn't modelled any "sudden step function" from agentic AI, and Cadence still can't isolate the agentic contribution as its own number. (Recap, not a stance call.) | article ↗ |
| HOOD | Robinhood Markets | QT · SA · STK · FA | Neutral | Firing on all cylinders — and still falling. Q2 revenue +32% Y/Y to $1.31B ($30M beat) and GAAP EPS $0.62 ($0.19 beat), though $0.14 came from a one-time Robinhood Ventures Fund I deconsolidation gain (ex-item $0.48, still ahead of ~$0.43). The stock fell anyway, down more than 20% in 2026 despite a business CFO Shiv Verma called "firing on all cylinders." The crypto-dependence worry got answered: transaction revenue +44% to $776M with options +29% to $342M, equities +95% to $129M and event contracts up more than 10x to $156M, more than covering crypto revenue falling 38% to $100M. Record $22B of net deposits, Gold subscribers 4.8 million, ARPU recovered from $157 to $187. The new bets scale fast: Trump Accounts already drew nearly $1.5B from 7 million children; prediction markets moved onto Rothera, the Susquehanna joint venture that became a top-3 US designated contract market within a month (answering whether the business survives the end of football season); agentic trading and Robinhood Chain launched, with 13 business lines above $100M in annualised revenue. FY26 adjusted opex/SBC guidance was lowered and tightened to $2.675–2.775B even after absorbing Rothera and the WonderFi acquisition. The platform grew 33% with crypto revenue down almost 40% — "the multiple reset has to be about crypto sentiment more than Robinhood's own execution." (Recap, not a stance call.) | article ↗ |
| MDLZ | Mondelez International | QT · SA · STK · FA | Neutral | North America turns. Q2 revenue +4% Y/Y to $9.4B ($150M beat) and adjusted EPS −3% to $0.73 ($0.05 beat) on operating declines and higher interest expense. Organic sales grew 2.2%, well above the ~0.9% consensus, with North America organic +3.4% — a sharp reversal from Q1's 0.5% crawl — and CEO Dirk Van de Put claiming share gains in every category. Emerging markets still lead: Asia/Middle East & Africa +7.1% and Latin America +8.4% on distribution expansion (100,000 stores added in India; Brazil now at 1 million). The margin story flipped from Q1's cocoa hangover — adjusted gross margin +20 bps to 34.0% against a ~32.8% consensus after Q1's 270-bp compression, with COO Luca Zaramella calling cocoa "a very different place" from the crisis and citing a 0.5 million-ton surplus. Europe is the new soft spot at −3.5% organic as Mondelez held trade stock in check through a heat wave. FY26 organic revenue guidance raised to at least 2% (vs ~1.9% consensus) while adjusted EPS growth was held at flat-to-5%, reinvesting any upside to protect 2027 — the bottom-line hold despite a raised top line is the tell that management still sees enough risk to reinvest. (Recap, not a stance call.) | article ↗ |
| HLT | Hilton Worldwide | QT · SA · STK · FA | Neutral | Mid-scale rebounds — on data centers. Q2 revenue +7% Y/Y to $3.34B ($20M beat), adjusted EPS $2.29 ($0.02 beat), adjusted EBITDA $1.05B clearing the high end of guidance; system-wide RevPAR +3.9% on a 5% jump in the US. Q3 adjusted EPS guidance fell short at $2.28–$2.34 against a $2.43 consensus. CEO Chris Nassetta named mid-scale and upper mid-scale in the US (limited-service hotels at moderate prices) as the biggest flip — from negative last year to strong growth — and tied it to an unexpected driver: the AI data-center buildout, because the contractors and engineers doing that work stay in mid-range hotels, not luxury. The drags are concentrated and mostly known: Middle East and Africa RevPAR fell about 30% on the Iran conflict (better than feared; now guided to a high-single to low-double-digit full-year decline), China RevPAR dropped 2.2% on government restrictions curbing group travel, and CFO Kevin Jacobs flagged $17M of timing items plus ~$20M of Middle East impact that kept Q2 outperformance from flowing through. FY26 RevPAR guidance raised to 3%–3.5% (from 2%–3%) and adjusted EPS to $8.89–$9.01, net unit growth held at 6%–7%; Q3 RevPAR +4% on the World Cup before Q4 softens on calendar shifts and midterm elections. "If data center spending is really driving mid-scale growth, that demand shouldn't fade until the buildout does." (Recap, not a stance call.) | article ↗ |
| RACE | Ferrari | QT · SA · STK · FA | Neutral | Scarcity pays. Q2 revenue +8% Y/Y to €1.94B, topping the ~€1.88B estimate, and adjusted EPS €2.62 (€0.12 beat); EBITDA €755M at a 39% margin, operating margin 31%, net profit +~9% to €463M. The formula is scarcity: Ferrari is deliberately managing deliveries down through a model changeover, yet earnings rose because the mix skewed richer — the €3.6 million F80, a hybrid supercar limited to 799 units, is now contributing (Citi estimates 60–70 delivered in the quarter), and personalisation exceeded 20% of revenue from cars and spare parts, which CEO Benedetto Vigna named as the main driver of the raise. The order book is full through 2027. FY26 guidance raised to revenue of ~€7.6B and adjusted EBITDA of at least €2.97B, with adjusted EPS lifted to €9.68 — and Ferrari rarely raises in Q2, so doing it signals confidence. The open question is the Luce, its first all-electric car: a €550,000 four-door designed with Jony Ive's LoveFrom that drew a rocky reception in May. It reportedly hit its ~500-unit 2026 target, but the next three years of volume rest largely on an EV the market met with skepticism once the F80 tops out. Watch whether the Luce holds pricing power in Q3. (Recap, not a stance call.) | article ↗ |
| F | Ford Motor | QT · SA · STK · FA | Neutral | Trucks cover the damage. Q2 adjusted EPS $0.66 ($0.31 beat) — but the headline carried a $1.3B one-time IEEPA tariff benefit; excluding one-time items, adjusted EPS was $0.37 ($0.02 beat). Total revenue −4% Y/Y to $48.3B, with a $1.3B net loss on $4.2B of pretax charges, mostly the disclosed $3.6B EV joint-venture wind-down. US sales fell 10%, yet Ford delivered high-margin Bronco and Explorer SUVs (especially off-road trims) to offset fewer F-Series pickups: Ford Blue revenue rose 1% despite an 8% wholesale decline, lifting EBIT margin 180 bps, and Ford Pro stayed the profit engine. Three drags: Model e is still bleeding (revenue −56% after the F-150 Lightning discontinuation, EBIT margin −90%, full-year EV loss guided to ~$4B); the Novelis aluminum fire drives most of Ford's $1B-plus tariff bill per CFO Sherry House, with the mill restarted in Q2 and ~$2.5B of lost F-Series production expected to recover; and USMCA is being renegotiated after the US declined to renew it — a live second-half risk given Ford's Mexican and Canadian footprint. FY26 adjusted EBIT guidance raised to $10–11B (from $8.5–10.5B), a $1B midpoint lift topping GM's $500M raise the week before. The mix premium is the only thing holding the line while EVs lose money. (Recap, not a stance call.) | article ↗ |
| PYPL | PayPal Holdings | QT · SA · STK · FA | Neutral | The $60 question. Q2 revenue +5% Y/Y to $8.7B ($230M beat) and adjusted EPS −1% to $1.38 ($0.10 beat), with TPV +9% to $486B. Earlier in July, Stripe and private-equity firm Advent bid roughly $60 a share, valuing PayPal above $53B — which the board reportedly saw as undervaluing the company, after shares had rallied about 35% over the prior month, the best on record. On the deal, Lores said only that the board would "carefully consider" any path that creates superior value while insisting the standalone plan is the focus. PayPal lifted FY26 adjusted EPS to ~$5.38 (vs $5.31 consensus) and full-year transaction margin dollars to ~$15.6B, tying the raise to execution. Underneath, the operating story is steadier than the drama: Braintree volume accelerated to 13%, a ninth straight quarter of profitable growth, and Venmo is being pushed from peer-to-peer toward a money-management platform; branded checkout TPV growth held at 2%, the same as Q1; free cash flow $1.8B funded $1.5B of buybacks with share count down 10% Y/Y; transaction margin dollars +1% to $3.9B and the $1.5B savings program pacing toward $400M this year. Q3 EPS is expected to decline low-single-digit. "The real question is whether Lores's raised guidance is a genuine turnaround signal or a negotiating stance, and the next move belongs to Stripe." (Recap, not a stance call.) | article ↗ |
| COIN | Coinbase Global | QT · SA · STK · FA | Neutral | Winning a smaller market. Q2 revenue −19% Y/Y to $1.22B ($60M miss) and a GAAP loss per share of −$1.36 (missing by $0.94); adjusted EBITDA fell to $208M from $303M in Q1 and shares dropped about 14% post-earnings. Transaction revenue dropped 22% to $599M as weak crypto prices and muted retail activity extended the downturn, and subscription and services revenue fell 12% to $555M. Coinbase still gained share: its portion of crypto trading volume reached a record 10.3%, up from 8.6% in Q1 and 7.1% a year ago; derivatives volume nearly matched its all-time high; prediction-market activity more than doubled sequentially; Coinbase One reached record subscribers; and USDC held on the platform climbed to $20B. Management says the "Everything Exchange" is working, with Bitcoin transactions now just 12% of revenue — but diversification remains too small to offset the broader crypto slowdown. Q3 subscription and services revenue is guided to $500–$580M, well below the $635M consensus, and the 2026 adjusted expense outlook was cut to $4.20–$4.45B. "It is taking share in a shrinking market." (Recap, not a stance call.) | article ↗ |
| LYV | Live Nation Entertainment | QT · SA · STK · FA | Neutral | World tour expands. Q2 revenue +9% Y/Y to $7.7B ($160M beat) and GAAP EPS $1.05 ($0.40 beat), with adjusted operating income of $817M. International markets drove it: attendance +10% to a record 49 million fans, concert revenue +8% to $6.4B, Ticketmaster +15% to $852M, sponsorship +12% to $383M — with international contributing 70% of Ticketmaster's profit growth and 80% of Sponsorship's, and attendance at international stadiums, arenas and festivals growing more than 20% while US stadium attendance declined on a second-half-weighted schedule. Ticketmaster also appears to have absorbed the pullback in secondary ticketing: fee-bearing ticket volumes grew high single digits, the full-year Ticketmaster profit outlook was raised to mid-single-digit growth, and secondary now represents only about 5% of global transaction value. Ticket sales through mid-July reached 143 million, event-related deferred revenue hit a record $6.4B, and cancellations fell to 1.1%; CEO Mike Rapino said there were "no consumer issues" across venues or geographies. FY26 now expects double-digit growth in attendance, revenue and adjusted operating income with margin expansion. The legal overhang hasn't disappeared, but the operating story is back where Live Nation wants it. (Recap, not a stance call.) | article ↗ |
| CMG | Chipotle Mexican Grill | QT · SA · STK · FA | Neutral | Momentum meets a wobble. Q2 revenue +9% Y/Y to $3.3B ($30M miss) and adjusted EPS flat at $0.33 ($0.01 beat), but comparable sales grew 2.2% — accelerating sharply from Q1's 0.5% — with transactions +1.0% and check +1.2%, so traffic is contributing and the recovery isn't a one-quarter blip. Shares jumped nearly 14%. The Recipe for Growth playbook keeps working: HEEP (high-efficiency equipment package) is in more than 1,000 restaurants, tracking to ~2,000 by year-end, and digital hit 38% of sales on the mid-April Rewards relaunch. Two things temper it: restaurant-level margin fell to 25.2% from 27.4% on beef, freight and labor inflation running 3–3.5%, which CEO Scott Boatwright is deliberately not passing to a stretched consumer; and CFO Adam Rymer flagged that trends "softened in recent weeks," guiding Q3 comps to just ~1% against the year's toughest lap, partly on a cyclospora food-safety headline Chipotle says it isn't involved in. FY26 comp guidance raised to low-single-digit growth (from roughly flat), openings held at 350–370, $631M of stock bought back. The top-line recovery is credible; the unresolved question is whether margins stop falling in the second half. (Recap, not a stance call.) | article ↗ |
| YUM | Yum! Brands | QT · SA · STK · FA | Neutral | Pizza Hut heads out. Q2 revenue +12% Y/Y to $2.2B ($10M miss) and adjusted EPS $1.62 ($0.06 beat), with same-store sales +3% led once again by Taco Bell: Taco Bell comps +7%, KFC +2% (unit count +7%), Pizza Hut −1%, and digital sales mix excluding Pizza Hut at 61%. Yum agreed to sell Pizza Hut for $2.7B across two transactions, ending a review launched last year — excluding Pizza Hut, system sales grew 7%, unit count rose 6% and same-store sales increased 4%, leaving a faster-growing portfolio centred on Taco Bell and KFC. That concentration creates a new risk, and it arrived immediately: after the quarter ended, a cyclospora outbreak linked to supplier lettuce hit Taco Bell traffic, with US same-store sales down 2% through July 27, although management said trends improved sharply over the final ten days and online sentiment returned to normal. Before the outbreak Taco Bell was exceptional — system sales +9%, restaurant margins +170 bps to 26.2%, digital mix 47%. Selling Pizza Hut removes the weakest chain and improves the growth profile, but makes Taco Bell more important than ever. (Recap, not a stance call.) | article ↗ |
| HSY | The Hershey Company | QT · SA · STK · FA | Neutral | Price over volume. Q2 revenue +7% Y/Y to $2.8B ($160M beat) and adjusted EPS +57% to $1.90 ($0.47 beat), with gross margin expanding to 45.3% from 30.5% on pricing, lower cocoa costs and productivity. But growth came almost entirely from 12 points of price against an 8-point volume/mix decline — Hershey is protecting profit by charging more, and it's costing volume. North American salty snacks surged 23%, helped by the LesserEvil acquisition, though the segment's profitability was weaker than expected; North American confectionery grew 4.2% on price with double-digit volume declines underneath, leaving organic growth at just 3.6%. FY26 guidance raised — sales growth to 4.5–5% and adjusted EPS to $8.36–$8.52 — with CFO Steve Voskuil expecting confectionery volumes to recover as cocoa inflation eases and shoppers adjust to higher prices, and management optimistic on an early Halloween. The bull case is falling cocoa costs while the price increases hold. Watch North American confectionery volume in Q3: "pricing this far ahead of volume isn't durable growth… the 12-point price lever becomes a ceiling rather than an engine." (Recap, not a stance call.) | article ↗ |
| RBLX | Roblox | QT · SA · STK · FA | Neutral | Monetization trade-off. Q2 revenue +36% Y/Y to $1.47B and a GAAP loss per share of $(0.26), a $0.07 beat — but bookings grew only 8% to $1.56B, missing by $40M; DAUs +10% to 123 million yet sequentially down; hours engaged +5% to 29 billion; monthly unique payers +15% to 27 million. Shares fell about 14% after hours as the problem shifted from user acquisition to monetization. New-user sign-ups improved and retention stayed stable, but users — particularly those under 13 in the US and Canada — moved away from last year's highly monetized viral games toward newer and evergreen experiences that generate less spending per hour, and Roblox compounded the pressure by changing its discovery algorithm to prioritise 28-day retention over near-term monetization. Management argues better retention should eventually offset the spending reduction but declined to say when that crossover occurs. Age-check penetration reached 57% and DAUs are expected to return to sequential growth in Q3 on seasonality and reinstatement in Russia. The outlook was far worse: Q3 bookings guided to decline 14%–18% to $1.58–$1.65B with revenue growth slowing to 4%–10%, full-year guidance withdrawn, and Q3 free cash flow possibly between $(60)M and $5M as AI-infrastructure spending rises. (Recap, not a stance call.) | article ↗ |
| RDDT | QT · SA · STK · FA | Neutral | Monetization outruns users. Q2 revenue +61% Y/Y to $805M ($74M beat) and GAAP EPS $1.25 ($0.29 beat), with adjusted EBITDA more than doubling to $343M at a 43% margin. Advertising revenue grew 64% to $762M while ARPU jumped 36% to a record $6.18; Reddit Max adoption increased more than 60% Q/Q with product revenue up over 150%; other revenue including data licensing grew 24% to $43M. The concern remains user growth: global DAUs rose 18% to 130 million, but US users slipped sequentially to 53.2 million. Management said product improvements added users during the quarter but volatile search referrals offset the gains — with Google AI Overviews and chatbots increasingly summarising Reddit content, investors worry fewer search users will click through and become direct users. Reddit argues app users are worth several times more than search traffic and is prioritising feed quality, onboarding and retention, but visibility remains limited and Q2 will be the final quarter separating logged-in and logged-out users. Q3 revenue guided to $860–$870M, well above consensus, with adjusted EBITDA margin around 45%. "Reddit is monetizing its audience faster than almost any consumer platform. The unresolved question is whether it can keep growing that audience as AI changes search behaviors." (Recap, not a stance call.) | article ↗ | |
| RIVN | Rivian Automotive | QT · SA · STK · FA | Neutral | R2 hits the road. Q2 revenue +27% Y/Y to $1.7B ($90M beat) with GAAP EPS −$0.63, and consolidated gross profit of $179M (an 11% margin) versus a $206M gross loss a year ago. The mix keeps improving: automotive revenue +23% to $1.14B with the segment's gross loss narrowing to $36M from $335M; software and services +37% to $515M generating $215M of gross profit; deliveries rose to 12,194 vehicles, above management's 9,000–11,000 outlook. Rivian began delivering R2 to external customers and said reservation-to-order conversion is running meaningfully ahead of expectations; production remains constrained by the slowest-moving suppliers, with a plan to expand from one shift to two by the end of Q3. FY26 delivery guidance raised to 65,000–70,000 (from 62,000–67,000), adjusted EBITDA losses narrowed to $1.8–$2.0B, CapEx guidance cut $250M to $1.7–$1.8B, and R2 still expected to exit 2026 at positive gross profit though launch costs pressure automotive margins in Q3 before the ramp helps in Q4. Free cash flow was −$849M and Rivian raised another $1.3B in equity, with Volkswagen and Uber expected to contribute a further $1.25B later this year. "Q2 proved that R2 demand is not the immediate problem." (Recap, not a stance call.) | article ↗ |
| SOFI | SoFi Technologies | QT · SA · STK · FA | Neutral | Records meet a shrug. Q2 revenue +41% Y/Y to $1.2B ($80M beat) and adjusted EPS $0.12 ($0.01 beat), with adjusted EBITDA of $358M and a long list of new records — originations, members, products, tangible book value. Shares fell nearly 10% anyway, the same pattern as Q1's 14% drop; the stock is down more than 40% this year with the Muddy Waters short report still hanging over it. Loan originations hit a record $14.8B, +69%, led by student loans surging 170% to $2.7B as the federal government resumed collections and cut income-based repayment plans — but the more important shift is engagement: cross-buy accelerated to 51% of new products opened by existing members (from 43% in Q1 and 35% a year ago), and SoFi added twice as many products as members for the first time; fee-based revenue reached $472M, recovering from the Q1 miss. The drags: Tech Platform revenue fell 23% to $85M, still lapping the Chime exit — the segment SoFi pitches as its future, so the drag matters beyond the dollars — and guidance is again raise-and-hold (FY26 adjusted revenue lifted to $4.75–4.85B vs ~$4.70B consensus while adjusted EBITDA ~$1.6B and EPS ~$0.60 held flat), which reads as reinvestment or margin pressure. Default rates fell across both personal and student portfolios versus last quarter and last year, cutting against the Muddy Waters charge that SoFi was masking credit deterioration. (Recap, not a stance call.) | article ↗ |
| ALGN | Align Technology | QT · SA · STK · FA | Neutral | Scanners down. Q2 revenue +4% Y/Y to a record $1.06B (in line) and non-GAAP EPS $2.64 ($0.04 beat) despite a $0.23 FX drag. Clear Aligner revenue grew 8% to $871M on record volume of 691,800 cases (+7%), with APAC, EMEA and Latin America offsetting a flat North America. The consequential news came from the boardroom: Elliott is involved — Align is adding three independent directors, launched a strategic and operating-model review, and raised its 2026 buyback to $400–500M after the activist engagement. Systems & Services fell 11% to $185M, which management framed as deliberate: pushing lower-priced iTero scanners and leasing models to build the installed base and recurring revenue — trading upfront hardware for long-term treatment volume — with full-year segment guidance now down 6–8%. Align reiterated FY26 revenue growth of 3–4% but shifted the mix underneath: Clear Aligner volume up ~6% while ASP is expected flat to slightly down. It also booked a ~$37.5M UK VAT liability it intends to appeal. Watch whether Clear Aligner volume holds mid-single digits or better through Q3, because that's the engine carrying the model while the scanner transition drags reported revenue. (Recap, not a stance call.) | article ↗ |
| TDOC | Teladoc Health | QT · SA · STK · FA | Neutral | The BetterHelp pivot. Q2 revenue −4% Y/Y to $607M ($9M miss) with GAAP EPS −$0.21 ($0.04 beat) and adjusted EBITDA of $66M at an 11% margin — and shares collapsed about 29% the next day. Integrated Care, the enterprise side, grew 1% to $394M, while BetterHelp revenue fell 12% to $213M as the segment pivots from cash-pay to insurance-covered therapy, trading near-term revenue for a more durable model. The pivot is the whole story: roughly 70–80% of potential users now prefer insurance over cash-pay, and demand has outrun Teladoc's provider network, so it cut advertising to match capacity — accelerating the cash-pay decline. BetterHelp hit a national insurance footprint ahead of schedule and ran over 20,000 insurance sessions in a single week, an annualised run rate above $110M. FY26 revenue guidance was cut to $2.36–2.45B, about 5% below the midpoint and under the ~$2.51B consensus, entirely on the faster cash-pay runoff, while adjusted EBITDA of $271–303M was reaffirmed on tighter costs and lower ad spend — "that looks like discipline, but the ad cuts protecting EBITDA are the same thing starving the cash-pay funnel." A $110M insurance run rate is replacing a much larger cash-pay base falling faster. (Recap, not a stance call.) | article ↗ |
"View" here is referenced/neutral — App Economy Insights is financial-analysis journalism; this is a thirty-six-company earnings recap, not a set of buy/sell calls (BUY/SELL/HOLD ratings are shared only with App Economy Portfolio members; the author's disclosed holdings this issue are ASML and TSM, neither of which is covered in the body, so neither is given a row). Research: QT Qualtrim · SA Seeking Alpha · STK Stock Analysis. The "Source" links open the newsletter (no per-name timestamps — it's a written post). Companies named only in passing inside a section (SK Hynix, J&J, Roche, Nvidia, AWS, Google, Microsoft, BlackRock, Pratt & Whitney, Stripe, Advent, Uber, DoorDash, Susquehanna/Rothera, WonderFi, LesserEvil, Boyu Capital, Novelis, Volkswagen, GM, Delta, United, Citi, Elliott, Muddy Waters, Chime, Apogee Therapeutics, Recorded Future, Hexagon) are not given rows.
Apple had record June-quarter sales and the shares still fell 6%, because the problem is no longer demand — it's that Apple cannot build enough. Demand for iPhones and Macs came in higher than planned, and Apple had already committed its supply of the most advanced chips, so it has nothing left to flex. That shortage hits Macs now and spreads to iPhone and iPad next quarter, which is why the sales forecast came in light despite a strong product cycle. The other squeeze is memory chips: Tim Cook called the price surge a "hundred-year flood," Apple has already raised some Mac and iPad prices, and profit margins are set to step down again once the cheaper chips it bought earlier run out. This was Cook's last earnings call — John Ternus takes over in September and inherits both the strong cycle and the supply and margin pressure. A recap, not a call.
Free cash flow is what a company has left after paying for the buildings and equipment it needs. Meta earned $31.9 billion of cash from operations this quarter and spent $31.1 billion on AI data centres — leaving $784 million, a 91% collapse. It also borrowed $24.9 billion and bought back no shares at all. Nothing is broken; Meta can easily afford this. But it is the first quarter where the AI buildout ate the entire quarter's spare cash, and the spending floor keeps rising (now $130–145 billion for the year). Watch how it is now funding the next stage: for a new one-gigawatt campus in El Paso, BlackRock puts up the money and owns 80% while Meta owns 20% and rents the whole site — the commitment is the same, the upfront cash outlay is smaller. The consolation is that AI is already earning its keep inside advertising: 8% more ad clicks, 16% more conversions on Facebook, and its automated-ads product past a $75 billion annual pace. A recap, not a call.
Samsung just posted the best quarter in its history — revenue more than doubled and operating profit rose eighteenfold — almost entirely from memory chips, whose prices are soaring because AI systems need enormous amounts of them. The stock fell anyway, and is down over 40% from its June peak. That gap is the whole story of this issue. Management said the shortage now lasts through 2028 and has locked 60–70% of its most advanced memory capacity into multi-year contracts, so the near-term earnings look assured. But memory is a famously boom-and-bust business, and investors are refusing to pay up for peak-cycle profits they assume will reverse. Note the irony inside Samsung itself: its phone division swung to a loss, squeezed by the very component prices making its chip division rich. A recap, not a call.
Visa doesn't lend money; it runs the rails that card payments travel on and takes a small cut of everything that passes through. So the numbers that matter are volumes, and every one of them sped up: total payment volume passed $4 trillion in a single quarter for the first time, cross-border spending (the most profitable kind) grew 13%, and transaction counts accelerated. Two things to notice. Visa pays partner banks "incentives" to win their business, and those payments grew 18% — faster than revenue — which is the price of the volume growth. And on the same day it announced a stablecoin platform and an AI-shopping partnership with OpenAI, it cut about 2,600 jobs, 7% of staff, mostly in technology and product. Management trimmed the full-year outlook to the low end, blaming currency swings it expects to persist. A recap, not a call.
Last quarter investors worried that Middle East conflict was starting to dent cross-border travel spending — the highest-margin thing Mastercard processes — and that Mastercard, with more exposure there than Visa, would suffer most. It didn't: the impact moderated, cross-border growth held at 12%, and the extra exposure became an advantage. The more durable shift is that Mastercard is becoming less of a pure payments network and more of a services business — fraud prevention, cybersecurity and data products grew 20% and are now the faster half, helped by its Recorded Future acquisition. Margins widened to 61%, guidance went up, and it bought back $4.9 billion of stock. A recap, not a call.
AbbVie's old blockbuster, Humira, lost patent protection and is shrinking fast (down another 36%). The whole investment question is whether its two replacements grow faster than Humira falls. This quarter they did comfortably — Skyrizi up 24% and Rinvoq up 25%, and notably Skyrizi has not lost momentum even after Johnson & Johnson launched a rival pill. Brain and nervous-system drugs added a second engine, up 20%. The odd detail: AbbVie raised its sales forecast but cut its profit forecast, because it is buying Apogee Therapeutics for $10.9 billion and the deal dilutes near-term earnings. That's a deliberate trade — spending today's profit to extend the immunology franchise into the 2030s. A recap, not a call.
Lam sells the machines chipmakers use to build chips, so its orders lead the industry by a year or more. While most chip-related stocks sold off this season on fears that AI spending is peaking, Lam rose — because it guided next quarter to $8.1 billion against roughly $7.1 billion expected, more than 20% growth in a single quarter. That is a company telling you the buildout is accelerating, not fading. The demand is broadening too: sales into NAND flash memory doubled in one quarter, and advanced packaging (the technique used to stack memory next to AI processors) is guided to grow more than 70%. Management even raised its long-run profitability targets. The only constraint left is physical — whether customers can install tools as fast as Lam can ship them. A recap, not a call.
For years consumer-goods companies grew by raising prices while selling fewer units. Coca-Cola is deliberately doing the opposite: it held price increases to just 2% and let volume do the work — 5% more drinks sold, growth in every region, led by India, China, the US and Brazil. That's a healthier kind of growth, because it means people are actually buying more rather than paying more for less. Remarkably, profit margins still widened, and the World Cup sponsorship lifted core Coke and Powerade volumes. The stock hit a new high. Two known drags are coming: six fewer shipping days in the fourth quarter, and the sale of its African bottling arm, worth a 2–3% hit to reported revenue. With price growth capped on purpose, volume has to keep carrying it. A recap, not a call.
P&G's underlying sales were completely flat — no growth from volume, price, or mix — a clear step backwards from last quarter, with every division except beauty falling short. But the guidance is where the damage sits. The Iran war has pushed up the cost of raw materials, energy and shipping, and P&G says that will cost it about $1 billion after tax next year — roughly an 8% bite out of profit growth — with the forecast assuming oil stays near $90 a barrel, so any escalation makes it worse. The bull argument is that this is a macro problem, not a competitive one: P&G just gained share in Greater China for the first time in fifteen quarters. The test is the first half of next fiscal year, since management has promised sales will accelerate while it absorbs the worst of the cost hit up front. A recap, not a call.
Arm doesn't make chips. It designs the blueprints and collects a royalty every time someone else's chip using its design is sold — which historically meant smartphones. Phones are slowing, and that is why the stock fell 7–8% despite beating on every line. The bull case rests on the shift into data centres, and that part is working: royalties from data-centre chips more than doubled for the second quarter running, its server designs have shipped 1.5 billion processor cores, and Nvidia, Amazon, Google and Microsoft are all leaning in further. The number to watch is a mismatch of Arm's own making — it says the pipeline of demand for its AI-server processors now exceeds $2 billion, but its official forecast still counts only $1 billion of it, because that's all the manufacturing capacity it has secured. If it raises that figure, the data-centre story is real enough to outrun the phone slowdown. A recap, not a call.
KLA makes the inspection equipment that finds defects on chips during manufacturing — a small slice of the industry's spending, but one that grows when chips get harder to make, which AI chips certainly are. Its most useful disclosure is its estimate of what the whole industry will spend on equipment: it just raised that for 2026 to about $150 billion, from "$140 billion plus" three months ago, and said AI demand signals have strengthened materially since March. A caveat worth understanding: KLA buys memory chips for its own tools, those prices are rising, and it cannot reprice orders customers already placed — so roughly a 1% margin drag is locked in until 2027. The question is whether serving a bigger market comes at a structurally lower margin. Note the split figures reflect a ten-for-one stock split in June, so per-share numbers aren't comparable to older ones. A recap, not a call.
A drug company is worth what its pipeline will eventually sell, so a high-profile trial failure raises the question of whether everything behind it is also shakier. AstraZeneca's heart drug Wainua missed its main goal — rare for a company that claims a 75% trial success rate — and the stock is down this year as a result. This quarter was the rebuttal. Cancer drugs carried the business (Imfinzi for lung cancer up 27%, Enhertu for breast cancer up 31%), offsetting older drugs going off-patent, and the CEO pointed to positive results from six late-stage programmes while insisting the $80 billion 2030 revenue goal already assumes failures like Wainua and needs no acquisitions to reach. More than twenty trial readouts land over the next eighteen months; two — Datroway in lung cancer and camizestrant in breast cancer — will decide whether that target is credible. A recap, not a call.
Airbus has cut its delivery target late in the year three times in four years, so the only question that mattered was whether it would do it again. It didn't: it delivered 351 aircraft in the first half against 306 last year, with the acceleration concentrated in the second quarter after a dismal first, and profit jumped 54%. That was enough to make the full-year goal of about 870 look reachable. Two things to keep watching. Cash flow was negative €1.2 billion because Airbus is deliberately building inventory ahead of the ramp, and a shortage of Pratt & Whitney engines still limits how fast it can go. And the arithmetic is demanding: roughly 519 more aircraft have to ship in the second half to hit 870, so either the monthly rate holds or the back-half crush strains suppliers again. A recap, not a call.
Qualcomm has one enormous known problem: Apple is replacing Qualcomm's modem chips with its own, and this quarter Qualcomm admitted the loss is coming faster than it had said — its share of the new iPhone will be "materially lower" than the 20% previously guided. The company's whole answer is diversification, and that part is genuinely working: car chips grew 61%, and two custom data-centre silicon wins start generating revenue in December, letting it raise its 2029 non-phone target to $40 billion. The near-term pinch is the same memory shortage hurting everyone — it compresses Qualcomm's chip margins, which is why next quarter's profit guidance came in well below expectations, and why Qualcomm is pushing through double-digit price increases from September 1. The diversification is ahead of plan; it just has to outrun a modem business disappearing faster than expected. A recap, not a call.
For Boeing, the single number that matters is cash: after years of burning it, the company generated $631 million this quarter versus losing $200 million a year ago. Deliveries hit 171 aircraft, the most since 2018, and the order backlog reached a record $715 billion — meaning demand is not the issue; the factory is. Boeing is lifting 737 output from 42 a month toward 47 and then 52, and that ramp is what the full-year cash target depends on. Two honest asterisks. The quarter's cash was helped by roughly $1.5 billion of customer prepayments, and a $700 million legal payment to the Justice Department hits next quarter. And the fixed-price Air Force One contract took another $280 million charge — it is four years late with more than $1 billion of overruns that Boeing, not the government, absorbs. A recap, not a call.
"Comparable sales" measures growth at stores open more than a year — it strips out new openings, so it shows whether the existing business is actually getting better. Starbucks grew 8% globally and 8% in the US, with a quarter of that from more customers walking in rather than higher prices. That's the fourth straight positive quarter after seven negative ones, and it accelerated. Revenue fell 1% only because Starbucks handed 60% of its China business to a partner and no longer consolidates it. The caution is on margins: the headline 4.3-point improvement leaned on tariff refunds covering three quarters of duties plus a favourable tax comparison, and management said the year-to-date view is the fairer read — North America's own margin barely moved, from 13.3% to 13.6%. The test is whether that keeps expanding once the refunds stop. A recap, not a call.
Fortinet sells network security — traditionally firewall hardware, increasingly a cloud-delivered service called SASE that protects employees wherever they work. Every number accelerated from an already-strong quarter: revenue up 26%, new business signed ("billings") up 33%, cash flow more than tripled, and the striking one — 90% of its large enterprise customers now use its SASE product, up from 18% three months ago. The thing to watch is the mix. Hardware revenue grew 52% while the recurring subscription half grew only 14%. Hardware is lumpy, one-off revenue; subscriptions are the durable kind. So the beat was front-loaded with the less repeatable part, and management has also assumed a price increase will help second-half bookings. Subscription growth is the number that tells you whether this is a genuine platform win. A recap, not a call.
UPS spent 18 months deliberately shrinking — walking away from about 2 million parcels a day of low-margin Amazon volume, cutting $4.5 billion of costs and a large slice of its workforce. This is the first quarter where revenue and operating profit both grew again, which suggests the reset worked. Amazon is now 9% of revenue, down from over 13% at the peak. What replaces it is higher-value freight: healthcare shipping passed $3 billion for the second quarter running, helped by refrigerated weight-loss drugs, and automated buildings now handle 68.5% of US volume at roughly 28% lower cost per parcel. The reported profit still looks awful because of an $891 million charge for the job cuts — that's a one-off. With the shrinking done and the costs booked, the second half is where the efficiency should finally show up in profit. A recap, not a call.
Cadence makes the software chip designers use to design chips. The most interesting idea in this issue comes from its CEO: when customers point AI agents at their design work, the agents call Cadence's simulation engines far more often than a human would. So AI shows up not as new software licences but as heavier usage of software customers already pay for — a consumption business rather than a per-seat one, which is exactly the model investors have been penalising elsewhere. Backlog hit a record $8.1 billion and the company made the largest single-quarter forecast increase in its history. Two honest notes: margins in the second half are guided lower because Cadence is deliberately investing, and management still refuses to model any sudden jump from AI agents — it can't even separate out how much of today's growth they represent. A recap, not a call.
The bear case on Robinhood was simple: it's a crypto brokerage in disguise, so when crypto falls, it falls. This quarter tested that directly — crypto revenue dropped 38% — and the platform grew 33% anyway, because options rose 29%, stock trading rose 95%, and event contracts (bets on real-world outcomes) rose more than tenfold to $156 million. Deposits hit a record $22 billion and revenue per customer recovered sharply. New businesses are scaling faster than expected: government-backed "Trump Accounts" pulled in $1.5 billion from 7 million children, and its prediction-market venture with Susquehanna became a top-three US exchange within a month, answering the worry about what happens when football season ends. Management even lowered its expense forecast. And the stock is still down more than 20% this year — which the article reads as a verdict on crypto sentiment rather than on Robinhood's execution. A recap, not a call.
Mondelez (Oreo, Cadbury, Milka) spent the past year absorbing a cocoa price crisis that crushed its margins. That has flipped: its chief operating officer says cocoa is now "a very different place," with a half-million-tonne surplus, and gross margin rose instead of falling. The bigger surprise was North America, which went from crawling at 0.5% growth to 3.4%, with management claiming share gains in every category, while emerging markets kept compounding on sheer distribution — 100,000 new stores added in India, a million now in Brazil. Europe is the new weak spot. The revealing detail is that Mondelez raised its sales forecast but left its profit forecast alone, saying it will reinvest any upside — companies do that when they still see enough risk ahead that they'd rather buy insurance than book the profit. A recap, not a call.
The standout detail in this issue comes from an unlikely place. Hilton's biggest improvement was in mid-priced, limited-service US hotels — a segment that was shrinking last year — and its CEO attributed it to the AI data-centre construction boom: the contractors and engineers building those sites stay in mid-range hotels, not luxury ones. It's a rare, concrete second-order read on where AI capital spending actually lands in the real economy, and it implies that demand persists as long as the buildout does. The offsetting drags are geopolitical and known: Middle East and Africa revenue per room fell about 30% on the Iran conflict, and China fell on government limits to group travel. Hilton raised its full-year outlook, though next quarter's profit guidance came in below expectations. A recap, not a call.
Ferrari's business model is the opposite of every other carmaker: it deliberately sells fewer cars than people want, so the waiting list stays long and prices stay high. That's why it can cut deliveries during a model changeover and still grow profit — the mix got richer, led by the €3.6 million F80 hybrid supercar limited to 799 units, and by personalisation (bespoke paint, trim and options) which now exceeds 20% of revenue. The order book is full through 2027 and Ferrari raised its guidance in a quarter when it almost never does, which is its way of signalling confidence. The open risk is the Luce, its first electric car — a €550,000 four-door designed with Jony Ive's studio that got a cool reception in May. It hit its ~500-unit target for the year, but once the F80 finishes its run, three years of volume rest largely on an EV the market isn't yet sure about. A recap, not a call.
Ford's headline earnings look far better than the business: a one-time $1.3 billion tariff refund flattered them, and stripping the one-offs out leaves $0.37 a share rather than $0.66. Underneath, the pattern is familiar — trucks and SUVs pay for everything else. US sales fell 10%, but Ford sold more high-margin Broncos and Explorers to offset fewer F-150s, and its commercial arm stayed the profit engine, while electric vehicles lost money at an extraordinary rate (a negative 90% margin, roughly $4 billion of losses expected this year). Two second-half risks are worth tracking: a fire at the Novelis aluminium mill drove most of Ford's $1 billion-plus cost hit, and the North American trade agreement (USMCA) is being renegotiated after the US declined to renew it, which matters given Ford's Mexican and Canadian plants. Ford still raised its full-year profit forecast by $1 billion, beating GM's raise the week before. A recap, not a call.
PayPal is in play. In July, Stripe (a private payments company) teamed with private-equity firm Advent to bid about $60 a share, valuing PayPal above $53 billion — and the board reportedly thinks that undervalues it, which is a meaningful judgement given the shares had already run up 35% in a month. Management would only say it will "carefully consider" any path that creates superior value. Underneath the drama the business is steadier than the headlines: Braintree, the behind-the-scenes processing arm, grew 13% for a ninth straight profitable quarter, cash flow funded $1.5 billion of buybacks, and PayPal raised its full-year profit forecast. The weak spot is the part everyone recognises — the branded PayPal checkout button — still growing only 2%. The genuinely unanswerable question is whether that raised forecast is a real turnaround signal or a negotiating position. A recap, not a call.
Coinbase is doing everything right competitively and it isn't enough. Its share of all crypto trading hit a record 10.3%, up from 7.1% a year ago; derivatives volume nearly matched an all-time high; prediction markets more than doubled; and stablecoin balances on the platform reached $20 billion. But revenue still fell 19% and it posted a large loss, because the market it dominates is shrinking — crypto prices are weak and retail traders have gone quiet. Management's answer is the "Everything Exchange," broadening into products beyond Bitcoin trading (Bitcoin is now just 12% of revenue), and it has cut its expense outlook. The honest summary from the article: the diversification is real, it just isn't big enough yet to break Coinbase's dependence on the crypto cycle. Next quarter's subscription revenue is guided well below expectations. A recap, not a call.
Live Nation promotes concerts, owns venues and runs Ticketmaster, so it earns from the same fan three times. A record 49 million people attended its shows, up 10%, and almost all the incremental growth came from outside the US — international markets provided 70% of Ticketmaster's profit growth and 80% of sponsorship's, with attendance at overseas stadiums and festivals up more than 20%. US stadium attendance fell simply because more shows are scheduled later this year. One worry got answered: the crackdown on resale (secondary) ticketing hasn't hurt, because resale is only about 5% of transaction value and Ticketmaster's fee-bearing volumes still grew. Deferred revenue — money already collected for future events — hit a record $6.4 billion, and cancellations fell to 1.1%, both signs demand is real rather than promotional. The antitrust overhang hasn't gone away. A recap, not a call.
Restaurant sales grow either because more people come in (traffic) or because each person spends more (ticket). Chipotle's recovery is the better kind: same-store sales accelerated to 2.2% from 0.5%, and transactions actually rose — so people are coming back, not just paying more. The shares jumped nearly 14%. The trade-off is on the other side of the income statement. Beef, freight and labour are inflating at 3–3.5%, and the CEO is deliberately not passing that on to a stretched customer, so restaurant-level margin fell from 27.4% to 25.2%. Management also warned that trends "softened in recent weeks" and guided next quarter to only about 1% growth against a tough comparison, partly on a food-safety news story Chipotle says doesn't involve it. The top-line recovery is credible; whether margins stop falling is the open question. A recap, not a call.
Yum agreed to sell Pizza Hut for $2.7 billion, removing its weakest brand. The maths of that is flattering: excluding Pizza Hut, system sales grew 7%, units grew 6% and same-store sales grew 4% — a visibly better company centred on Taco Bell and KFC. But concentration cuts both ways, and the risk showed up immediately. After the quarter closed, a cyclospora outbreak traced to supplier lettuce hit Taco Bell, and US same-store sales fell 2% through late July, though management says the last ten days improved sharply. Before that, Taco Bell was exceptional — system sales up 9%, restaurant margins up 1.7 points, nearly half of orders digital. So the next quarter answers a simple question: was the food-safety hit a blip, or the first reminder of what it means to depend this heavily on one brand? A recap, not a call.
Hershey's profit soared 57% and gross margin went from 30.5% to 45.3%, which sounds spectacular until you see how: twelve percentage points of price increases against an eight-point decline in volume. In other words, Hershey is protecting profit by charging more, and shoppers are buying less chocolate. Confectionery sales in North America grew 4.2% purely on price, with double-digit volume declines underneath. Management's bet is that cocoa costs are now falling while the higher prices stick, and that volumes recover as shoppers adjust — helped by an early Halloween. The article's caution is the right one: pricing this far ahead of volume isn't durable growth, and if shoppers don't come back as inflation eases, that twelve-point price lever becomes a ceiling rather than an engine. Watch North American confectionery volume next quarter. A recap, not a call.
Roblox changed what its recommendation algorithm optimises for — from short-term spending to whether a player is still around 28 days later — and it worked exactly as designed, in both directions. Players, especially under-13s in the US and Canada, drifted from last year's heavily monetised viral hits toward newer, longer-lasting games that generate less spending per hour. So "bookings" (money actually spent, the number that matters more than reported revenue) grew only 8% and missed, daily users fell sequentially, and the stock dropped 14%. Management argues better retention eventually more than pays for the lost spending, but wouldn't say when that crossover arrives — and then withdrew full-year guidance entirely while guiding next quarter's bookings to decline 14–18%. Last quarter it was safety changes hurting new-user growth; this quarter the fix brought a different cost. A recap, not a call.
Reddit is squeezing far more money out of each user than almost any consumer platform — revenue up 61%, average revenue per user up 36% to a record $6.18, and profit margins reaching 43%. The worry is the denominator. US daily users actually fell slightly, because a large share of Reddit's audience arrives via Google searches, and Google's AI summaries and chatbots increasingly answer the question on the results page using Reddit's own content — so fewer people click through and become regular users. Reddit's response is that app users are worth several times more than search visitors, so it's investing in feed quality, onboarding and retention instead of chasing search traffic. Next quarter's revenue guidance is well above expectations, so monetisation isn't the issue. Whether the audience keeps growing as AI reshapes search is. A recap, not a call.
Rivian's whole future rests on the R2, a cheaper SUV meant to take it from niche to volume, and this quarter it started delivering them to outside customers — with more reservation-holders converting to actual orders than management expected. Demand, in other words, is not the problem. The economics also improved sharply: the company made an 11% gross profit versus a large loss a year ago, and the car-making segment's loss shrank from $335 million to $36 million, helped by a fast-growing software and services business. Deliveries beat its own forecast and full-year guidance went up. What's left is execution and cash: production is limited by its slowest suppliers, it burned $849 million in the quarter, and it raised another $1.3 billion by selling shares, with $1.25 billion more expected from Volkswagen and Uber. Scaling without letting launch costs swamp the improving unit economics is the test. A recap, not a call.
SoFi set records on nearly every measure — loans originated (up 69% to $14.8 billion), members, products, book value — and the stock fell 10%, the same as last quarter, leaving it down over 40% this year. The most encouraging number isn't the headline: 51% of new products were opened by existing members, up from 35% a year ago, and SoFi added twice as many products as members for the first time. That's the "one-stop financial app" thesis actually working. Two things weigh on it. The technology-platform division, which SoFi has pitched as its future, fell 23% as it laps the loss of the Chime contract. And a short-seller report from Muddy Waters alleging hidden credit problems still hangs over the shares — though default rates actually fell this quarter across both personal and student loans, which cuts against that claim. Guidance raised revenue but left profit flat, which reads as reinvestment or margin pressure. A recap, not a call.
Align makes Invisalign clear braces and the iTero 3D scanners dentists use to fit them. Its scanner revenue fell 11% — deliberately. Align is pushing cheaper scanners and leasing deals to get more machines into more practices, on the logic that every installed scanner generates years of aligner cases afterwards. It's trading a one-off hardware sale for recurring treatment volume, and it will depress reported revenue while the transition runs. Meanwhile the activist investor Elliott has engaged: Align is adding three independent directors, launched a strategic and operating-model review, and raised its buyback to $400–500 million. Aligner volumes hit a record and grew 7%, carried by Asia, Europe and Latin America while North America was flat. The number that matters next quarter is aligner volume — that's the engine paying for the scanner transition. A recap, not a call.
BetterHelp, Teladoc's online-therapy business, historically charged patients directly out of pocket. It is switching to billing insurance instead — because 70–80% of prospective patients would rather use insurance — which should build a much stickier business but costs revenue immediately. That's a defensible strategy; the execution is what broke the stock, which fell about 29%. Demand for insurance-covered therapy outran the number of therapists Teladoc has, so it cut advertising to stop generating demand it can't serve — and that same ad cut is what's accelerating the decline of the old cash-pay business. Teladoc cut its revenue forecast by about 5% while keeping its profit forecast intact on lower spending, which looks like discipline but is the very thing starving the funnel. The arithmetic problem: a $110 million insurance run rate is replacing a much larger cash-pay base that's falling faster. A recap, not a call.
Key points & figures extracted from the App Economy Insights PRO newsletter (in transcript.txt) for personal study. Not investment advice. © App Economy Insights for source material.